Learning from the report of the independent medicines and medical devices safety review: “first do no harm”

Author:

Krishnaswamy Priyanka H1ORCID,Ledingham Marie-Anne2,Tyagi Veenu3,Guerrero Karen Lesley3

Affiliation:

1. Subspecialty Registrar in Urogynaecology, Queen Elizabeth University Hospital, Glasgow, UK

2. Maternal Fetal Medicine Consultant, Queen Elizabeth University Hospital, Glasgow, UK

3. Subspecialist Urogynaecology Consultant, Queen Elizabeth University Hospital, Glasgow, UK

Abstract

This is a review of the learning points from the Independent Medicines and Medical Devices Safety Review, 1 chaired by Baroness Julia Cumberlege CBE DL. This system-wide review was initiated by the then Secretary of State for Health and Social Care, following patient-led campaigns. It looked at how the “healthcare system reacted as a whole, and how that response can be made more robust, speedy and appropriate”. We aim to highlight the learning points for doctors in Obstetrics and Gynaecology as these are relevant to our current practice and future changes in our healthcare system. These are: Aims of the review: why it was initiated and how it was conducted Overarching themes and missed opportunities to prevent avoidable harm Three clinical scenarios: their histories, issues and adverse events associated with their use and the current response in Scotland The hormone pregnancy test - Primodos The anti-epileptic drug - sodium valproate Surgical mesh for prolapse & incontinence The recommendations made by the review and implementation guidance Responses to the review, such as apologies issued by BSUG 2 /BAUS 3 /RCOG, 4 and compensations schemes such as the Scottish scheme as recommended by the review

Publisher

SAGE Publications

Subject

General Medicine

Reference29 articles.

1. Independent Medicines and Medical Devices Safety Review. First Do No Harm- The report of the Independent Medicines and Medical Devices Safety Review [Internet]. 2020 [cited 2020 Jul 16]. Available from: https://www.immdsreview.org.uk/downloads/IMMDSReview_Web.pdf(accessed 16 July 2020).

2. British Society of Urogynaecology. BSUG apology in response to the Report of Independent Medicines and Medical Devices Safety Review [Internet]. 2020 [cited 2021 Feb 11]. Available from: https://bsug.org.uk/news-details/bsug-apology-in-response-to-the-report-of-independent-medicines-and-medical-devices-safety-review-/95/0/0

3. British Association of Urological Surgeons. Statement to BAUS members following publication of the Cumberlege Report [Internet]. 2020 [cited 2020 Aug 18]. Available from: https://www.baus.org.uk/patients/sui_mesh_complications.aspx

4. Royal College of Obstetricians & Gynaecologists. President's response to the Independent Medicines and Medical Devices Safety Review [Internet]. [cited 2020 Aug 18]. Available from: https://www.rcog.org.uk/en/guidelines-research-services/patient-safety/mesh/

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3